Atra stock forecast.

Analyst projections state that ATRA is forecast to be at a low of $0.40 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -4207.69% from its current level, while the stock would need to crash 38.46% from its current level to reach the projected low.QUALCOMM Stock Forecast 12-06-2023. Forecast target price for 12-06-2023: $ 131.60. Positive dynamics for QUALCOMM shares will prevail with possible volatility of 2.676%. Pessimistic target level: 129.02. Optimistic target level: 132.57.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.

According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00.

Stock Price Forecast. According to 16 stock analysts, the average 12-month stock price forecast for AT&T stock is $20.03, which predicts an increase of 19.51%. The lowest target is $14 and the highest is $28. On average, analysts rate AT&T stock as a buy.23 brokers have issued 1 year price targets for Advanced Micro Devices' shares. Their AMD share price targets range from $80.00 to $200.00. On average, they expect the company's share price to reach $134.77 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.

Aug 21, 2023 · ATRA stock forecast Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the Aug. 21, 2023 when the stock price was at 1.41$. In the short term (2weeks), ATRA's stock price should underperform the market by -2.71%. During that period the price should oscillate between -13.09% and +13.51%. Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Find real-time ATRA - Atara Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.16 sept 2020 ... See if the stock goes on to build a promising consolidation that could kick off a new price move. Atara Biotherapeutics (ATRA).Atara Biotherapeutics stock forecast for 18.11.2023. Estimated Average Forecasted Atara Biotherapeutics Price: 1.92 Positive intraday dynamics of the instrument is expected with 2.384% volatility is expected. Pessimistic forecast: 1.89. Optimistic: 1.93. Atara Biotherapeutics stock forecast for 19.11.2023.

High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year.

Nov 20, 2023 · Atara Biotherapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Atara Biotherapeutics analysts is $ 4.14 . Today 200 Day Moving Average is the resistance level ( 2.216 $).

ATRA Stock Predictions, Articles, and Atara Biotherap News From InvestorPlace From the Web Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday By William White, ...T Stock 12 Months Forecast. Based on 15 Wall Street analysts offering 12 month price targets for AT&T in the last 3 months. The average price target is $19.82 with a high forecast of $28.00 and a low forecast of $16.00. The average price target represents a 26.81% change from the last price of $15.63.Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025.QUALCOMM Stock Forecast 12-06-2023. Forecast target price for 12-06-2023: $ 131.60. Positive dynamics for QUALCOMM shares will prevail with possible volatility of 2.676%. Pessimistic target level: 129.02. Optimistic target level: 132.57.According to 11 Wall Street analyst s that have issued a 1 year T price target, the average T price target is $18.32, with the highest T stock price forecast at $22.00 and the lowest T stock price forecast at $14.00. On average, Wall Street analysts predict that AT&T 's share price could reach $18.32 by Oct 23, 2024.16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.

Orchid Island Capital (NYSE:ORC) pays an annual dividend of $1.44 per share and currently has a dividend yield of 19.54%. ORC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ORC.Atara Biotherapeutics, Inc. (ATRA) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 0.6478 -0.0122 (-1.85%) At close: 04:00PM EST 0.6223 -0.03 ( …4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.Mar 30, 2023 · Should You Buy or Sell Atara Biotherapeutics Stock? Get The Latest ATRA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Aug 8, 2023 · Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecastsNTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.

What is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 …

Jun 30, 2023 · ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comOct 27, 2023 · Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions. According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecastsIf you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...Oct 9, 2023 · Mizuho Securities analyst Salim Syed has maintained their bullish stance on ATRA stock, giving a Buy rating on September 26.. Salim Syed’s rating of Atara Biotherapeutics as a Buy is driven by a ... Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...Stock Price Forecast. According to 33 stock analysts, the average 12-month stock price forecast for Apple stock is $197.09, which predicts an increase of 3.05%. The lowest target is $120 and the highest is $240. On average, analysts rate Apple stock as …GDX Signals & Forecast. Mostly positive signals in the chart today. The VanEck Vectors Gold Miners ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long …

Nov 22, 2023 · According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

Find real-time META - Meta Platforms Inc stock quotes, company profile, news and forecasts from CNN Business.

SmartAssetPaid Partner. Find real-time T - AT&T Inc stock quotes, company profile, news and forecasts from CNN Business.1 equities research analysts have issued twelve-month price objectives for Astra Space's stock. Their ASTR share price targets range from $15.00 to $15.00. On average, they anticipate the company's share price to reach $15.00 in the next year. This suggests a possible upside of 971.4% from the stock's current price.ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.HRTX Stock 12 Months Forecast. $9.00. (1402.00% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Heron Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 1402.00% change from the last price of $0.60.With the interplay of data, predictions, and real-time performance, Atara Biotherapeutics's stock emerges not just as an investment opportunity but as a narrative unfolding in the grand theatre of the financial markets. Each high, low, surge, and dip is a chapter, and every investor, a reader and co-author of this evolving tale.ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $5.05 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 890.20% change from the last price of $0.51.Nov 24, 2023 · THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl... 4 days ago - Business Wire Atara Biotherapeutics To Participate at the Stifel Healthcare Conference NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.Nov 16, 2023 · It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecasts The latest Atara Biotherapeutics stock prices, stock quotes, news, and ATRA history to help you invest and trade smarter. ... The 18 analysts offering price forecasts for Atara Biotherapeutics ... If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

The average Geovax Labs stock price prediction forecasts a potential upside of 1,542.71% from the current GOVX share price of $0.49. What is GOVX's forecast return on equity (ROE) for 2026-2026? (NASDAQ: GOVX) forecast ROE is N/A, which is considered weak.Atara Biotherapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Atara Biotherapeutics analysts is $ 14.72 . Today 200 Day Moving Average is the resistance level ( 2.335 $).CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.Nov 7, 2023 · Analyst projections state that ATRA is forecast to be at a low of $1.40 and a high of $31.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2248.48% from its current level, while the stock would need to crash -6.06% from its current level to reach the projected low. Instagram:https://instagram. acad50 dollar stockswrnt stockstockmarket holiday ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $5.05 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 890.20% change from the last price of $0.51. KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62. state farm motorcycle insurance ratesmgm hotel stocks Nov 27, 2023 · Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (2.683 $). ferrari 4 door ATRA | Atara Biotherapeutics, Inc. Healthcare NASDAQ 📈 Technical Chart Patterns & Trend Analysis 📉 Identifying potential trading opportunities based on trend analysis: bullish divergence can be seen oh daily time frame and aslo a double bottom indicating a trend reversal. BUY STOP will be good option in this scenario . 📊 Technical analysis helps id 📈 …NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.